CN111514161A - Anti-oral ulcer preparation and application thereof - Google Patents

Anti-oral ulcer preparation and application thereof Download PDF

Info

Publication number
CN111514161A
CN111514161A CN202010466888.3A CN202010466888A CN111514161A CN 111514161 A CN111514161 A CN 111514161A CN 202010466888 A CN202010466888 A CN 202010466888A CN 111514161 A CN111514161 A CN 111514161A
Authority
CN
China
Prior art keywords
accounts
ulcer
preparation
polysaccharide
calcium salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202010466888.3A
Other languages
Chinese (zh)
Other versions
CN111514161B (en
Inventor
李秋雁
徐志良
张咪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Xuebao Daily Chemical Co ltd
Original Assignee
Jiangsu Xuebao Daily Chemical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Xuebao Daily Chemical Co ltd filed Critical Jiangsu Xuebao Daily Chemical Co ltd
Priority to CN202010466888.3A priority Critical patent/CN111514161B/en
Publication of CN111514161A publication Critical patent/CN111514161A/en
Application granted granted Critical
Publication of CN111514161B publication Critical patent/CN111514161B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/191Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses an anti-oral ulcer preparation which is characterized by comprising the following components in percentage by mass: the cuttlebone polysaccharide 1 accounts for 80-90%, the lactobionic acid accounts for 2-20%, the calcium salt accounts for 0.05-1%, and the plant preservative accounts for 0.5-1%. The anti-canker sore preparation can be used for preparing products for treating canker sore, such as film, ointment, powder, granules, toothpaste, mouthwash, mouth spray and the like. The invention takes marine organism polysaccharide cuttlebone polysaccharide 1 as a main mucous membrane repairing component, relieves inflammatory reaction, and promotes healing of ulcer tissues and repairing of sore surfaces; lactobionic acid and calcium salt, which play a role in buffering and synergism in the repair process; the natural plant-derived preservative is mild and safe, and has no stimulation or anaphylactic reaction.

Description

Anti-oral ulcer preparation and application thereof
Technical Field
The invention belongs to the technical field of oral care, and particularly relates to an anti-oral ulcer preparation capable of relieving oral ulcer and application thereof.
Background
Recurrent oral ulcer is one of the most common oral mucosa diseases, early pathological manifestations are mucosa edema, then epithelial blisters are generated, and dissolution, mucosa ulceration and necrosis are gradually generated to prevent shedding, so that superficial ulcer is formed. The blood vessels at the ulcer are congested and dilated, cellulose exudation appears, a large amount of inflammatory cells infiltrate, and pseudomembranous or necrotic tissues are formed at the focus. The focus can be self-healed in 10-14 days, and no scar is formed generally.
Recurrent oral ulcer has certain periodicity and is easy to recur, the pathogenic reason is not clear at present, and the recurrent oral ulcer can be related to a plurality of factors such as vitamin and trace element deficiency, immunologic function reduction, bacterial infection, local trauma, digestive system diseases and the like. At present, traditional Chinese medicine, western medicine or Chinese and western medicine are adopted for combined treatment, the traditional Chinese medicine is usually used for clearing away heat and toxic materials, promoting tissue regeneration and healing sores, the western medicine is usually used for resisting bacteria, diminishing inflammation and relieving pain, the frequency of ulcer occurrence can be reduced, the severity of ulcer occurrence can be relieved, an ideal method for preventing recurrence is not provided, and the method is worthy of further research and exploration.
The marine polysaccharide derived from marine animals, plants and microorganisms has the biological activities of enhancing immunity regulation, reducing blood sugar, regulating blood fat, resisting virus, resisting tumor, resisting blood coagulation, resisting aging, resisting inflammation and the like, and has wide application prospects in the fields of food, daily chemicals, medicines and the like. The cuttlebone polysaccharide 1 is a natural active polysaccharide derived from cuttlebone of a marine traditional Chinese medicine, has the effects of resisting oxidation and improving the levels of Epidermal Growth Factor (EGF) and platelet-derived growth factor (PDGF), and has fewer application researches in the oral cavity field.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provide a mild and non-irritant oral ulcer resisting preparation which can relieve inflammatory reaction, promote healing of ulcer tissues and repair of sore surfaces and is application thereof.
In order to achieve the purpose, the invention adopts the following technical scheme:
the anti-oral ulcer preparation is characterized by comprising the following components in percentage by mass: the cuttlebone polysaccharide 1 accounts for 80-90%, the lactobionic acid accounts for 2-20%, the calcium salt accounts for 0.05-1%, and the plant preservative accounts for 0.5-1%.
Under pathological conditions such as chronic inflammation and tumor, the expression of tumor necrosis factor-a (TNF-a) is increased. The increase of TNF-a of patients with recurrent oral ulcer can promote the release of various chemokines, oxygen free radicals, elastin and the like, further aggravate tissue lysis, edema and ulceration and cause tissue structural damage. After TNF-a is increased, inflammatory factors such as TNF-a and interleukin-6 (IL-6) are activated to generate, the content of IL-6 of a recurrent oral ulcer patient is increased, cell proliferation and differentiation and apoptosis are stimulated, and the TNF-a and the IL-6 interact to aggravate oral ulcer symptoms. The cuttlebone polysaccharide 1 can improve the activity of superoxide dismutase, clear away oxygen free radicals, relieve the injury of mucosal cells and adjust the inflammatory reaction of mucosal injury; meanwhile, the composition stimulates epidermal growth factors, reduces the generation of TNF-a, relieves inflammatory symptoms and promotes the repair and healing of ulcer surfaces.
Lactobionic acid has strong oxidation resistance, can chelate iron ions, reduces the damage of hydroxyl radicals generated by ion catalysis to tissues, and strengthens wound repair.
It is further characterized in that: the calcium salt is calcium carbonate or calcium gluconate. The calcium salt can form a high-permeability state in interstitial fluid after being applied to the ulcer surface, so that the fibrin is precipitated and the cell division and proliferation are promoted, thereby accelerating the healing of the ulcer surface.
Preferably: the plant preservative is a zanthoxylum bungeanum maxim extract or a forsythia suspensa maxim extract. The fructus zanthoxyli extract contains active ingredients such as limonene, cumic alcohol, dragon's geraniol, phytosterol, benzoic acid, unsaturated organic acid, diosmin and alkaloid, and the fructus forsythiae extract contains active ingredients such as hypericin, triterpenoid saponin, phytosterol, forsythol, alkaloid, saponin, oleanolic acid and coumarins, and the active ingredients can easily penetrate through a cell membrane structure to interfere the permeability of a microbial cell membrane and hinder the absorption of the cell membrane to amino acid, so that the physiological activity of the microbe is disordered, and the antibacterial effect is achieved. The extracts of the wild pepper fruits and the forsythia suspense which are natural plant sources cooperate with each other to resist bacteria, have no stimulation to mucous membranes, and are safe and mild.
The anti-canker sore preparation can be used for preparing products for treating canker sore, such as film, ointment, powder, granules, toothpaste, mouthwash, mouth spray and the like.
The toothpaste adopting the anti-canker sore preparation has no adverse reaction in the using process. Compared with the toothpaste of a control group, the toothpaste of a test group has obvious difference (p is less than 0.05) in the healing time and the recurrence frequency of the ulcer, and the toothpaste of the test group has clinical effects of promoting the healing of the ulcer and reducing the recurrence frequency of the ulcer.
Compared with the prior art, the invention has the advantages that: the invention takes marine organism polysaccharide cuttlebone polysaccharide 1 as a main mucous membrane repairing component, relieves inflammatory reaction, and promotes healing of ulcer tissues and repairing of sore surfaces; lactobionic acid and calcium salt, which play a role in buffering and synergism in the repair process; the natural plant-derived preservative is mild and safe, and has no stimulation or anaphylactic reaction.
Detailed Description
The present invention will be described in further detail with reference to examples, which are provided for illustration only and are not intended to limit the scope of the present invention. The test methods used in the following examples are all conventional methods unless otherwise specified; the materials, reagents and the like used are, unless otherwise specified, commercially available reagents and materials.
Example 1
1. Preparation of cuttlebone polysaccharide 1
Weighing a certain amount of cuttlebone powder with the granularity of 80-100 meshes, and adding the cuttlebone powder into a sodium acetate solution with the pH of 6.5 to ensure that the material-liquid ratio is 1: 30, of a nitrogen-containing gas; heating to 55 deg.C, adding papain for enzymolysis for 4 hr with enzyme amount of 4%; after enzymolysis, quickly heating to 90 ℃, and inactivating enzyme for 10 min; centrifuging at 8000r/min for 10min, adding ethanol into the supernatant, precipitating with ethanol overnight, centrifuging, and freeze drying the supernatant to obtain Os Sepiae crude polysaccharide; dissolving Os Sepiae crude polysaccharide with distilled water, separating and purifying with ion exchange gel column and molecular sieve gel column, and freeze drying the obtained collected solution to obtain Os Sepiae polysaccharide-1.
2. Preparation of anti-oral ulcer preparation
Adding 80% of cuttlebone polysaccharide-1, 15% of lactobionic acid, 0.5% of calcium carbonate/calcium gluconate and 1% of zanthoxylum fruit extract/fructus forsythiae extract into a high-speed mixer in percentage by mass, fully and uniformly mixing, standing in a granulator for 8-15min, drying and cooling to obtain the anti-oral ulcer preparation.
3. Preparation of toothpaste containing dental ulcer preparation
(1) Sterilization
Adding a certain amount of pure water and water-soluble materials (saccharin sodium and sodium dihydrogen phosphate) into a sterilizing pot, stirring to dissolve, and sterilizing.
(2) Premixing
Adding a certain amount of humectants such as sorbitol and glycerol into a premixing pot.
(3) Powder feeding
Adding 10% of the anti-canker sore preparation into a homogenizing container, starting a vacuum pump matched with the homogenizing container, and sucking the materials in a sterilizing pot and a premixing pot into the homogenizing container; sucking powder (anti-canker sore preparation, hydroxypropyl guar gum, cellulose gum, xanthan gum, hydrated silica and calcium hydrophosphate) into a corresponding homogenizing container by using a vacuum pump (the vacuum degree P is approximately equal to-0.06 MPa); and after powder suction is finished, controlling the vacuum degree P to be-0.06 MPa to-0.09 MPa and the temperature T to be less than 40 ℃, quickly stirring for about 20min, and stopping stirring after stirring is finished.
(4) Stirring the mixture
Sucking sodium lauroyl sarcosinate, cocamidopropyl betaine, hydrated silica and calcium hydrophosphate into corresponding homogenizing containers by using a vacuum pump (the vacuum degree P is approximately equal to-0.06 MPa); after the powder is sucked, controlling the vacuum degree P between-0.06 MPa and-0.09 MPa and the temperature T less than 40 ℃, and quickly stirring for about 20 min.
(5) Degassing of gases
After stirring, controlling the vacuum to be 0.07MPa and the temperature T to be less than 40 ℃, and sucking the essence into a homogenizing container by using a vacuum pump. After the addition of the essence, the mixture was homogenized and degassed for 20 minutes (from the moment when the essence vacuum reaches the maximum) and the preparation was complete.
4. Evaluation of clinical efficacy of toothpaste containing oral ulcer preparation in relieving light recurrent aphthous ulcer
Subjects were interviewed back at baseline, 4 weeks, 8 weeks for oral condition assessment using a randomized double-blind parallel control design.
(1) Grouping tests: subjects were randomized into two groups, 36 subjects in the test group and 35 subjects in the control group.
(2) The using method comprises the following steps: the subjects brushed their teeth 2 times per day for at least 2 min. During the ulcer attack, the subject needs three meals and then rinses with clear water, the toothpaste is smeared on the affected part, and the mouth is rinsed after 5 min. Subjects were able to use only the indicated test toothpastes, and prohibited the use of other therapeutic agents that promote ulcer healing, including VC and the like. The test toothpaste is used on site when the subject visits for the first time, the teeth are brushed and the affected part is smeared once as required, and the change of the pain index is recorded.
(3) Test results
Comparing two groups of base lines
The distribution of the sex and the ulcer positions of the test group subjects and the control group subjects is balanced, and the difference has no statistical significance; the age, number of ulcers, time to ulcer appearance when included in the study, baseline pain values, allergic history and differences in dietary habits were not statistically significant for the patients in the test and control groups, see table 1.
TABLE 1 Baseline comparison
Figure BDA0002512956360000041
② clinical effects
Compared with the healing time and the recurrence frequency of the ulcer of a control group, the difference of the test group and the control group has statistical significance; the differences in pain values after use were not statistically significant in the test and control groups, see table 2. Adverse reactions did not occur in the test process of all the subjects, and the incidence rate of the adverse reactions was 0%.
TABLE 2 evaluation of clinical Effect
Evaluation index Test group Control group Statistical value P value
Healing time (Tian) 5.66±2.02 7.46±2.69 t=3.11 0.0027
Frequency of recurrence (times) 3.06±1.48 4.40±2.89 t=2.42 0.0189
Pain value after use 3.00±1.66 2.66±1.51 t=-0.91 0.3661
Compared with the toothpaste of a control group, the toothpaste of a test group has obvious difference (p is less than 0.05) in the healing time and the recurrence frequency of the ulcer, and the toothpaste of the test group has clinical effects of promoting the healing of the ulcer and reducing the recurrence frequency of the ulcer.

Claims (4)

1. The anti-oral ulcer preparation is characterized by comprising the following components in percentage by mass: the cuttlebone polysaccharide 1 accounts for 80-90%, the lactobionic acid accounts for 2-20%, the calcium salt accounts for 0.05-1%, and the plant preservative accounts for 0.5-1%.
2. The anti-canker sore formulation of claim 1 wherein: the calcium salt is calcium carbonate or calcium gluconate.
3. The anti-canker sore formulation of claim 1 or 2 wherein: the plant preservative is a zanthoxylum bungeanum maxim extract or a forsythia suspensa maxim extract.
4. Use of an anti-canker sore formulation as defined in any one of claims 1-3 in a film, ointment, powder, granule, toothpaste, mouthwash, mouthspray for the treatment of canker sores.
CN202010466888.3A 2020-05-28 2020-05-28 Anti-oral ulcer preparation and application thereof Active CN111514161B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010466888.3A CN111514161B (en) 2020-05-28 2020-05-28 Anti-oral ulcer preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010466888.3A CN111514161B (en) 2020-05-28 2020-05-28 Anti-oral ulcer preparation and application thereof

Publications (2)

Publication Number Publication Date
CN111514161A true CN111514161A (en) 2020-08-11
CN111514161B CN111514161B (en) 2021-05-04

Family

ID=71909282

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010466888.3A Active CN111514161B (en) 2020-05-28 2020-05-28 Anti-oral ulcer preparation and application thereof

Country Status (1)

Country Link
CN (1) CN111514161B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112402368A (en) * 2020-11-27 2021-02-26 马梅伍 Oral mucosa protective cream and manufacturing equipment thereof
CN113069405A (en) * 2021-04-27 2021-07-06 广州优妥生物科技有限公司 Antibacterial toothpaste for relieving oral ulcer and preparation method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512599A2 (en) * 1991-05-09 1992-11-11 Unilever N.V. Phosphorylated polyhydroxy compounds for tartar control
US5310542A (en) * 1991-12-31 1994-05-10 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing antiplaque agents
CN1635864A (en) * 1999-06-30 2005-07-06 瑞·J·余 Oligosaccharide aldonic acids and their topical use
CN101897726A (en) * 2010-07-28 2010-12-01 张玉芹 Traditional Chinese medicinal powder for treating oral ulcer
CN107837276A (en) * 2016-09-19 2018-03-27 刘力 The pharmaceutical composition being locally administered
CN110151626A (en) * 2019-06-19 2019-08-23 云南省药物研究所 A kind of toothpaste containing cuttlebone and pollen pini

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0512599A2 (en) * 1991-05-09 1992-11-11 Unilever N.V. Phosphorylated polyhydroxy compounds for tartar control
US5310542A (en) * 1991-12-31 1994-05-10 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions containing antiplaque agents
CN1635864A (en) * 1999-06-30 2005-07-06 瑞·J·余 Oligosaccharide aldonic acids and their topical use
CN101897726A (en) * 2010-07-28 2010-12-01 张玉芹 Traditional Chinese medicinal powder for treating oral ulcer
CN107837276A (en) * 2016-09-19 2018-03-27 刘力 The pharmaceutical composition being locally administered
CN110151626A (en) * 2019-06-19 2019-08-23 云南省药物研究所 A kind of toothpaste containing cuttlebone and pollen pini

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘群等: "海螵蛸多糖的酶法提取工艺条件的研究", 《食品科技》 *
罗江: "海螵蛸多糖1治疗复发性口腔溃疡的疗效", 《江苏医药》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112402368A (en) * 2020-11-27 2021-02-26 马梅伍 Oral mucosa protective cream and manufacturing equipment thereof
CN113069405A (en) * 2021-04-27 2021-07-06 广州优妥生物科技有限公司 Antibacterial toothpaste for relieving oral ulcer and preparation method thereof

Also Published As

Publication number Publication date
CN111514161B (en) 2021-05-04

Similar Documents

Publication Publication Date Title
CN110882207B (en) Preparation process and method of essence for skin repair
CN102600494B (en) Polysaccharide combination and preparation method and application thereof
CN111514161B (en) Anti-oral ulcer preparation and application thereof
US10786443B2 (en) Method for protecting skin by using orchid callus extract
CN108272862B (en) Pudilan oral spray and preparation method thereof
CN113520896A (en) Composition with acne removing and acne mark repairing functions and preparation method thereof
CN106728744A (en) A kind of composition and its preparation of the promotion anti-scar of wound healing
CN111671692A (en) Acne-removing composition and preparation method and application thereof
CN109394850B (en) Traditional Chinese medicine composition with skin aging delaying effect, aqueous extract and fermentation product of traditional Chinese medicine composition and application of traditional Chinese medicine composition
CN114028546A (en) Composite polypeptide sterilization preparation and preparation method and application thereof
CN104306853A (en) Chitosan quaternary ammonium salt-rhizoma galangae essential oil compound antibacterial aerosol and preparation method and application thereof
CN108078868B (en) Antiallergic composition for skin care products
CN116236439A (en) Colloidal silver antibacterial gel and preparation method and application thereof
CN107158051B (en) Tannic acid ointment for treating eczema and preparation method thereof
CN112274548B (en) External composition with wound healing effect and preparation method and application thereof
CN113456735B (en) Inactivated probiotic herbal gel and preparation method and application thereof
CN114848721A (en) Acne-removing composition containing plant extracts and preparation application thereof
CN107982300B (en) Spray and preparation method and application thereof
CN112245332A (en) Eczema gel containing marine oligosaccharide
CN104027298A (en) Lentinan gelata and preparation method thereof
Akbar et al. Aloe vera (L.) Burm. f.(Asphodelaceae/Xanthorrhoeaceae) (Syns.: A. barbadensis Mill.; A. chinensis Steud. ex Baker; A. elongata Murray; A. vulgaris Lam.)
CN109432005A (en) A kind of allergic dermatitis spray containing marine oligosaccharide
CN111686189B (en) Plant composition for treating red wind buttocks and application thereof
EP2628487B1 (en) Adjuvant composition for topical use
CN114699336B (en) Facial mask containing lysozyme

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant